|
CN102b: Phase I/II UCBMC Transplant Trial |
This umbilical cord blood mononuclear cell transplant trial is eligible to
assess the safety and feasibility of transplanting cord blood
mononuclear cells into chronic spinal cord injury patients. The trial started in Jan 2010 in Hong Kong and completed at the end of 2013.
Participating Sites (listed in no particular order): The University of Hong Kong/Queen Mary Hospital and The Chinese University
of Hong Kong/Prince of Wales Hospital.
Principal Investigators (listed in no particular order): Dr. Gilberto LEUNG and Dr. Wai Sang POON
No. of Subjects enrolled: 8
Sponsorship (listed in no particular order): Hong Kong Spinal Cord Injury Fund and Stemcyte Inc.
For more information, please refer to:
Clinicaltrials.gov: NCT01046786
What should I do if I would like to participate in the trials of ChinaSCINet?
To learn as much as possible about the clinical trial and then
contact the investigator directly. You may also leave your basic
information and contact here (Submit a Form). The investigators may retrieve the data
and contact you if they think you might be suitable candidate for the
trial.
To read more:
About Clinical Research
About Lithium and Cord Blood Cells
|
